• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

New genetic drivers in hemorrhagic hereditary telangiectasia

9 de September de 2023
Eur J Intern Med. 2023 Sep 7:S0953-6205(23)00308-4. doi: 10.1016/j.ejim.2023.08.024.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2023-09-09 10:00:002023-09-09 10:00:00New genetic drivers in hemorrhagic hereditary telangiectasia

Potential angiogenic biomarkers in hereditary hemorrhagic telangiectasia and other vascular diseases

24 de May de 2023
Eur J Intern Med. 2023 Sep;115:10-17. doi: 10.1016/j.ejim.2023.05.020.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2023-05-24 10:00:002023-05-24 10:00:00Potential angiogenic biomarkers in hereditary hemorrhagic telangiectasia and other vascular diseases

Feasibility of extended ultrasound examination of the fetal brain between 24 and 37 weeks’ gestation in low-risk pregnancies

17 de April de 2023
J Perinat Med. 2023 Apr 18;51(6):815-822. doi: 10.1515/jpm-2022-0605.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2023-04-17 10:00:002023-04-17 10:00:00Feasibility of extended ultrasound examination of the fetal brain between 24 and 37 weeks’ gestation in low-risk pregnancies

Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer

14 de November de 2022
Adv Sci (Weinh). 2022 Nov 14;10(1):e2204211. doi: 10.1002/advs.202204211.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-11-14 11:00:002022-11-14 11:00:00Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer

Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells

24 de August de 2022
Cell Death Dis. 2022 Aug 24;13(8):730. doi: 10.1038/s41419-022-05177-x.ABSTRACTOn…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-08-24 10:00:002022-08-24 10:00:00Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells

Rethinking growth factors: the case of BMP9 during vessel maturation

30 de March de 2022
Vasc Biol. 2022 Feb 7;4(1):R1-R14. doi: 10.1530/VB-21-0019. eCollection…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-03-30 10:00:002022-03-30 10:00:00Rethinking growth factors: the case of BMP9 during vessel maturation

Translational medicine in hereditary hemorrhagic telangiectasia

20 de September de 2021
Eur J Intern Med. 2022 Jan;95:32-37. doi: 10.1016/j.ejim.2021.09.003.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-09-20 10:00:002021-09-20 10:00:00Translational medicine in hereditary hemorrhagic telangiectasia

Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis

11 de August de 2021
EMBO Mol Med. 2021 Sep 7;13(9):e13929. doi: 10.15252/emmm.202113929.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-08-11 10:00:002021-08-11 10:00:00Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis

Adrenomedullin as a potential biomarker involved in patients with hereditary hemorrhagic telangiectasia

23 de April de 2021
Eur J Intern Med. 2021 Jun;88:89-95. doi: 10.1016/j.ejim.2021.03.039.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-04-23 10:00:002021-04-23 10:00:00Adrenomedullin as a potential biomarker involved in patients with hereditary hemorrhagic telangiectasia

PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-dependent manner

8 de January de 2021
Cancer Metab. 2021 Jan 7;9(1):1. doi: 10.1186/s40170-020-00236-3.ABSTRACTBACKGROUND:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-01-08 11:00:002021-01-08 11:00:00PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-dependent manner

FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma

2 de December de 2020
Clin Cancer Res. 2021 Mar 1;27(5):1491-1504. doi: 10.1158/1078-0432.CCR-20-0232.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2020-12-02 11:00:002020-12-02 11:00:00FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma

SGK1 is a signalling hub that controls protein synthesis and proliferation in endothelial cells

9 de August de 2020
FEBS Lett. 2020 Oct;594(19):3200-3215. doi: 10.1002/1873-3468.13901.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2020-08-09 10:00:002020-08-09 10:00:00SGK1 is a signalling hub that controls protein synthesis and proliferation in endothelial cells
Page 2 of 10‹1234›»

Filter by categories

  • Alemany’s & Piulats’s lab (131)
  • Antolin's lab (36)
  • Aytes's Lab (24)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sureda's & Farre's Lab (257)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}